In line with our results, silencing of BMI-1 in breast cancer cells was shown to impair Wnt signalling via downregulation of Wnt ligands (e.g. Wnt3a) and upregulation of Wnt inhibitors including DKK1. This evidence concerns the gene WNT3A and breast carcinoma.